Maria Sainz
CIK 1437768 · President and CEO · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.35M
Companies
10
Total Filings
68
Lifetime Open-Market Net
-$479.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLSE | Director | — | $35.23 | — | $0 | 2 | 2026-06-15 |
| Hyperfine, Inc. (QSIAW) Delisted | President and CEO | 789,586 | $0.01 | $5.4K | $17.4K | 8 | 2026-04-01 |
| Shockwave Medical, Inc. (SWAV) Delisted | Director | 0 | $334.75 | $0 | -$331.5K | 7 | 2024-05-31 |
| HYPR | Director | 19,586 | $0.92 | $18.1K | $0 | 3 | 2022-06-13 |
| ATRION CORP (ATRI) Delisted | Director | 284 | $459.92 | $130.6K | $0 | 3 | 2022-05-26 |
| AVNS | Director | 33,396 | $24.99 | $834.6K | $0 | 4 | 2022-01-05 |
| OFIX | Director | 40,871 | $11.75 | $480.2K | -$165.8K | 17 | 2020-06-10 |
| IRIX | Director | 16,894 | $0.82 | $13.9K | $0 | 3 | 2019-07-25 |
| AVANOS MEDICAL, INC. (HYH) Delisted | Director | 14,496 | — | — | $0 | 5 | 2018-05-04 |
| SPECTRANETICS CORP (SPNC) Delisted | Director | 34,276 | — | — | $0 | 6 | 2017-06-12 |
Recent Filings · Page 6 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-04 | AVANOS MEDICAL, INC. (HYH) Delisted | Grant (A) | +3,143 | $0 | EDGAR |
| 2015-01-05 | — | Grant (A) | +3,866 | $3.3K | |
| 2014-12-24 | — | Buy (P) | +23,310 | $0 | |
| 2014-10-02 | — | Grant (A) | +2,981 | $3.7K | |
| 2014-07-08 | OFIX | Grant (A) | +6,500 | $0 | EDGAR |
| 2014-07-02 | OFIX | Grant (A) | +6,500 | $0 | EDGAR |
| 2014-07-02 | — | Grant (A) | +3,594 | $3.7K | |
| 2014-03-03 | OFIX | Grant (A) | +1,900 | $0 | EDGAR |
| 2014-01-03 | — | Grant (A) | — | $0 | |
| 2013-09-27 | OFIX | Grant (A) | +3,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.